These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9359933

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. BSE--a risk for man through pharmaceutical products? Position and politics of the German pharmaceutical industry.
    Danner K.
    Dev Biol Stand; 1993; 80():199-205. PubMed ID: 8270110
    [Abstract] [Full Text] [Related]

  • 4. Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective.
    Kozak RW, Golker CF, Stadler P.
    Dev Biol Stand; 1996; 88():257-64. PubMed ID: 9119148
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Transmissible spongiform encephalopathies in animals].
    Fatzer R, Vandevelde M.
    Wien Med Wochenschr; 1998; 148(4):78-85. PubMed ID: 9611347
    [Abstract] [Full Text] [Related]

  • 7. Bovine sera used in the manufacture of biologicals: current concerns and policies of the U.S. Food and Drug Administration regarding the transmissible spongiform encephalopathies.
    Asher DM.
    Dev Biol Stand; 1999; 99():41-4. PubMed ID: 10404874
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The research advance of analytical methodology for detecting bovine spongiform encephalopathy].
    Wei C, Liu G, Ma G, Tian X, Jin P, Peng C.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Feb; 22(1):211-3. PubMed ID: 15762152
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Bovine spongiform encephalopathy in Europe. Present and future].
    Savey M, Belli P, Coudert M.
    Vet Res; 1993 Feb; 24(2):213-25. PubMed ID: 8343806
    [Abstract] [Full Text] [Related]

  • 18. Use of substances of animal origin in pharmaceutics and compliance with the TSE-risk guideline -- a market survey.
    Berger CN, Le Donne P, Windemann H.
    Biologicals; 2005 Mar; 33(1):1-7. PubMed ID: 15713551
    [Abstract] [Full Text] [Related]

  • 19. Safety of milk and milk derivatives in relation to BSE: the lactoferrin example.
    Vetrugno V.
    Biometals; 2004 Jun; 17(3):353-6. PubMed ID: 15222490
    [Abstract] [Full Text] [Related]

  • 20. Diagnostics for TSE agents.
    Raeber AJ, Oesch B.
    Dev Biol (Basel); 2006 Jun; 123():313-23; discussion 349-54. PubMed ID: 16566455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.